Rubinstein-Taybi syndrome and keloids

Rubinstein-Taybi syndrome and keloids - Rubinstein-Taybi syndrome and keloids

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON38183

Enrollment

Registered

2012-01-10

Start date

2012-04-02

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

itching scar keloid

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with the Rubinstein Taybi syndrome Patients with keloids Age 18 years or above Written informed consent For the biopsy study: the patient needs general anaesthesia for a planned intervention for patient care reasons

Exclusion criteria

Exclusion criteria: Insufficient understanding of the purpose of the study by parents / other legal representative Age

Design outcomes

Primary

Measure	Time frame
The clinical characteristics of keloids The histological characteristics of keloids The moleculair and cell-biological characteristics of keloids in RTS, mainly the TGF beta pathway and HAT function	—

Countries

Netherlands

Outcome results